IL17A and periodontitis: This study used network pharmacology to explore the therapeutic effect of CR in periodontitis, and then used molecular docking experiment and in vitro experiment to verify that BBR, the most effective chemical component in CR, can treat periodontitis through IL-17 signaling pathway and has anti-inflammatory effect.